Reigo Biotech-B (02179.HK) has had its application materials for issuing domestic shares accepted by the China Securities Regulatory Commission.

Gelonghui February 27th丨Recom Bio-B (02179.HK) announced that the company recently received the "China Securities Regulatory Commission Administrative License Application Acceptance Receipt" (Acceptance Serial Number: 250162) issued by the China Securities Regulatory Commission. The China Securities Regulatory Commission reviewed the application materials submitted by the company in accordance with the law, found that the application materials were complete, and decided to accept the administrative license application.

Gelonghui FinanceFeb 27 06:20 ET

Express News | Jiangsu Recbio Technology - Acceptance by Csrc of Application Materials for Issuance of Domestic Shares

ReutersFeb 27 06:18 ET

Trending Industry Today: CARSGEN-B Leads Gains In Pharmaceutical Companies Stocks

Moomoo NewsFeb 26 02:40 ET

Individual Investors Are Jiangsu Recbio Technology Co., Ltd.'s (HKG:2179) Biggest Owners and Were Rewarded After Market Cap Rose by HK$489m Last Week

Simply Wall StFeb 14 18:43 ET

Gelonghui announcement highlights (Hong Kong stocks) | SUNNY OPTICAL (02382.HK) earnings surprise: It is expected that the annual net profit will increase significantly by 140% to 150%.

【Today's Focus】SUNNY OPTICAL (02382.HK) profit warning: expected annual net profit to increase significantly by 140% to 150%. SUNNY OPTICAL (02382.HK) announced that the group anticipates a net profit attributable to Shareholders of approximately RMB 2.6386 billion to RMB 2.7485 billion for the year ending December 31, 2024, an increase of approximately 140.0% to 150.0% compared to around RMB 1.0994 billion for the year ended December 31, 2023. The Board of Directors believes that the expected increase is mainly due to the following reasons: 1. The recovery of the Smart Phone market.

Gelonghui FinanceFeb 12 09:47 ET

Express News | Jiangsu Recbio Technology - Acceptance of Application for Clinical Trial of Adjuvanted Recombinant Hpv 9-Valent Vaccine REC604C by Nmpa China

ReutersFeb 12 07:37 ET